The Long Pathway to Improving Clinical Decisions With Better Risk Markers: Recurrent Thrombosis After Myocardial Infarction

J Am Coll Cardiol. 2024 Oct 29;84(18):1730-1732. doi: 10.1016/j.jacc.2024.08.050.
No abstract available

Keywords: clinical decision rules; myocardial infarction; treatment effect heterogeneity.

Publication types

  • Editorial